| Literature DB >> 20957164 |
Yili Qu1, Ping Wang, Yi Man, Yubao Li, Yi Zuo, Jidong Li.
Abstract
Nano-hydroxyapatite/polyamide 66 (nHA/PA66) composite with good bioactivity and osteoconductivity was employed to develop a novel porous membrane with asymmetric structure for guided bone regeneration (GBR). In order to test material cytotoxicity and to investigate surface-dependent responses of bone-forming cells, the morphology, proliferation, and cell cycle of bone marrow stromal cells (BMSCs) of rats cultured on the prepared membrane were determined. The polygonal and fusiform shape of BMSCs was observed by scanning electronic microscopy (SEM). The proliferation of BMSCs cultured on nHA/PA66 membrane tested by the MTT method (MTT: [3-{4,5-dimethylthiazol-2yl}-2,5-diphenyl-2H-tetrazoliumbromide]) was higher than that of negative control groups for 1 and 4 days' incubation and had no significant difference for 7 and 11 days' culture. The results of cell cycle also suggested that the membrane has no negative influence on cell division. The nHA/PA66 membranes were then implanted into subcutaneous sites of nine Sprague Dawley rats. The wounds and implant sites were free from suppuration and necrosis in all periods. All nHA/PA66 membranes were surrounded by a fibrous capsule with decreasing thickness 1 to 8 weeks postoperatively. In conclusion, the results of the in vitro and in vivo studies reveal that nHA/PA66 membrane has excellent biocompatibility and indicate its use in guided tissue regeneration (GTR) or GBR.Entities:
Keywords: barrier membrane; biocompatibility; guided bone regeneration; hydroxyapatite/polyamide
Mesh:
Substances:
Year: 2010 PMID: 20957164 PMCID: PMC2950400 DOI: 10.2147/ijn.s10710
Source DB: PubMed Journal: Int J Nanomedicine ISSN: 1176-9114
Figure 1SEM photos of nHA/PA66 membrane: micropore surface (A) and spongy surface (B).
Figure 2SEM micrographs of the BMSCs cultured on the nHA/PA66 membranes for 24 h (A) and 96 h (B), respectively.
Figure 3The cellular morphology and proliferation of BMSCs cultured with nHA/PA66 membrane and BMSCs (control) under inverted phase contrast microscope (magnification:200×) at day 4 (A, B) and day 7 (C, D). M stands for nHA/PA66 membrane.
Figure 4The proliferation of BMSCs (control) and BMSCs cultured with nHA/PA66 membrane at various incubation periods.
Distribution in the different phases of BMSCs (control) and BMSCs cultured with nHA/PA66 membrane
| nHA/PA66 | 11.8 | 74.8 | 72.7 | 67.1 | 14.4 | 15.3 | 21.1 | 10.7 | 12.0 |
| Control | 12.4 | 77.9 | 81.8 | 50.2 | 13.6 | 11.4 | 37.4 | 8.5 | 6.8 |
Abbreviations: BMSCs, bone marrow stromal cells; nHA/PA66, nanohydroxyapatite/polyamide 66.
Figure 5Hematoxylin/eosin-stained sections of subcutaneously-implanted nHA/PA66 membrane and surrounding tissue, which were harvested at 1 (A), 4 (B), and 8 (C) weeks post-implantation (magnification:400×). In the photos, M denotes the nHA/PA66 membrane.